Ondokuz Mayıs University is a major state university founded in 1975 in Samsun, Turkey. The university bears the name “19 May”, which marks the date when Mustafa Kemal Atatürk, founder of the Republic of Turkey, came to Samsun in order to start the War of Independence.

During the past decade, Ondokuz Mayis University conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 2 clinical trials were completed, i.e. on average, 3.8% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 2 clinical trials were completed. i.e. 4.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ondokuz Mayis University" #1 sponsor was "Ondokuz Mayıs University" with 24 trials, followed by "Janssen Research & Development, LLC" with 9 trials sponsored, "Bayer" with 3 trials sponsored, "Samsun Liv Hospital" with 3 trials sponsored and "Diskapi Teaching and Research Hospital" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ondokuz Mayis University" #1 collaborator was "Ondokuz Mayıs University" with 5 trials as a collaborator, "Klinar CRO" with 2 trials as a collaborator, "Pharmacyclics LLC." with 2 trials as a collaborator, "Turkish Neurological Society" with 2 trials as a collaborator and "Abbott Nutrition" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Ondokuz Mayis University" are "Acute Pain" (4 trials), "Analgesia" (4 trials), "Anesthesia" (4 trials), "Nursing Caries" (3 trials) and "Patient Controlled Analgesia" (3 trials). Many other conditions were trialed in "Ondokuz Mayis University" in a lesser frequency.

Most popular intervention types in "Ondokuz Mayis University" are "Drug" (20 trials), "Other" (11 trials), "Procedure" (11 trials), "Behavioral" (8 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (4 trials), "Daratumumab" (3 trials), "Dexamethasone" (3 trials), "Placebo" (3 trials) and "Teclistamab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ondokuz Mayis University" are 43 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Ondokuz Mayis University". 1 are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Ondokuz Mayis University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ondokuz Mayis University, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 25 trials that are defined as “Not Applicable".

Ondokuz Mayis University has several departments that took part in Clinical trials: "Ondokuz Mayis Univ. Med. Fac.; Neurology" - 11 trials, "Ondokuz Mayis University School of Medicine; Neurology" - 8 trials, "Ondokuzmayis University Medical Faculty Heamatology Department" - 3 trials, "Ondokuz Mayıs University Dp. Endodontics, Faculty of Dentistry" - 2 trials